BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26275374)

  • 1. Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.
    Ayanwuyi LO; Stopponi S; Ubaldi M; Cippitelli A; Nasuti C; Damadzic R; Heilig M; Schank J; Cheng K; Rice KC; Ciccocioppo R
    Br J Pharmacol; 2015 Nov; 172(21):5136-46. PubMed ID: 26275374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429.
    Schank JR; Pickens CL; Rowe KE; Cheng K; Thorsell A; Rice KC; Shaham Y; Heilig M
    Psychopharmacology (Berl); 2011 Nov; 218(1):111-9. PubMed ID: 21340476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.
    Schank JR; Tapocik JD; Barbier E; Damadzic R; Eskay RL; Sun H; Rowe KE; King CE; Yao M; Flanigan ME; Solomon MG; Karlsson C; Cheng K; Rice KC; Heilig M
    Biol Psychiatry; 2013 Apr; 73(8):774-81. PubMed ID: 23419547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking.
    Schank JR; King CE; Sun H; Cheng K; Rice KC; Heilig M; Weinshenker D; Schroeder JP
    Neuropsychopharmacology; 2014 Apr; 39(5):1093-101. PubMed ID: 24173499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models.
    Sequeira MK; Nelson BS; Fulenwider HD; King CE; Nennig SE; Bohannon JB; Cheng K; Rice KC; Heilig M; Schank JR
    Neuropharmacology; 2018 Jul; 137():194-201. PubMed ID: 29758386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escalated Alcohol Self-Administration and Sensitivity to Yohimbine-Induced Reinstatement in Alcohol Preferring Rats: Potential Role of Neurokinin-1 Receptors in the Amygdala.
    Nelson BS; Fulenwider HD; Nennig SE; Smith BM; Sequeira MK; Chimberoff SH; Richie CT; Cheng K; Rice KC; Harvey BK; Heilig M; Schank JR
    Neuroscience; 2019 Aug; 413():77-85. PubMed ID: 31242442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking.
    Schank JR; Nelson BS; Damadzic R; Tapocik JD; Yao M; King CE; Rowe KE; Cheng K; Rice KC; Heilig M
    Neuropharmacology; 2015 Dec; 99():106-14. PubMed ID: 26188146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.
    Cannella N; Kallupi M; Li HW; Stopponi S; Cifani C; Ciccocioppo R; Ubaldi M
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2915-24. PubMed ID: 27235017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats.
    Borruto AM; Fotio Y; Stopponi S; Petrella M; De Carlo S; Domi A; Ubaldi M; Weiss F; Ciccocioppo R
    Neuropsychopharmacology; 2021 Nov; 46(12):2121-2131. PubMed ID: 34285372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral sensitization induced by dorsal periaqueductal gray electrical stimulation is counteracted by NK1 receptor antagonism in the ventral hippocampus and central nucleus of the amygdala.
    Carvalho MC; Veloni AC; Genaro K; Brandão ML
    Neurobiol Learn Mem; 2018 Feb; 148():60-68. PubMed ID: 29519453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake.
    Stopponi S; Fotio Y; Domi A; Borruto AM; Natividad L; Roberto M; Ciccocioppo R; Cannella N
    Addict Biol; 2018 Nov; 23(6):1223-1232. PubMed ID: 29071769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.
    Fulenwider HD; Smith BM; Nichenko AS; Carpenter JM; Nennig SE; Cheng K; Rice KC; Schank JR
    J Neuroinflammation; 2018 Feb; 15(1):60. PubMed ID: 29486768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin-1 receptor antagonist rolapitant suppresses anxiety and alcohol intake produced by repeated withdrawal episodes.
    Kokhan VS; Anokhin PK; Abaimov DA; Shamakina IY; Soldatov VO; Deykin AV
    FEBS J; 2022 Aug; 289(16):5021-5029. PubMed ID: 35175687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429.
    Singewald N; Chicchi GG; Thurner CC; Tsao KL; Spetea M; Schmidhammer H; Sreepathi HK; Ferraguti F; Singewald GM; Ebner K
    J Neurochem; 2008 Sep; 106(6):2476-88. PubMed ID: 18673452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dorsal periaqueductal gray post-stimulation freezing is counteracted by neurokinin-1 receptor antagonism in the central nucleus of the amygdala in rats.
    Carvalho MC; Santos JM; Brandão ML
    Neurobiol Learn Mem; 2015 May; 121():52-8. PubMed ID: 25883049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
    Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
    Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NK1 receptor antagonist L822429 reduces heroin reinforcement.
    Barbier E; Vendruscolo LF; Schlosburg JE; Edwards S; Juergens N; Park PE; Misra KK; Cheng K; Rice KC; Schank J; Schulteis G; Koob GF; Heilig M
    Neuropsychopharmacology; 2013 May; 38(6):976-84. PubMed ID: 23303056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats.
    Marinelli PW; Funk D; Juzytsch W; Harding S; Rice KC; Shaham Y; Lê AD
    Psychopharmacology (Berl); 2007 Dec; 195(3):345-55. PubMed ID: 17705061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of substance P-induced defensive behavior via neurokinin-1 receptor antagonism in the central and medial but not basolateral nuclei of the amygdala in male Wistar rats.
    Bassi GS; Carvalho MC; Almada RC; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():146-154. PubMed ID: 28390968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.